Stocks
Novo Nordisk (NVO) CAPEX/Revenue US GAAP (year values) |
|||||||||
| 2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| CAPEX/Revenue, % | 5.25% | 5.25% | 8.34% | 8.34% | 16.7% | 19.4% | |||
| Changes by years, y/y, % | -12pp | 0pp | +3pp | 0pp | +8pp | +8.6% | |||
Novo Nordisk. CAPEX/Revenue, %
Novo Nordisk. CAPEX/Revenue, changes, pp
Novo Nordisk (NVO) CAPEX/Revenue US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| CAPEX/Revenue, % | 13.0% | 18.1% | 25.0% | 13.8% | 19.5% | 19.4% | ||
| Changes by years, y/y, % | +7pp | +9pp | +12pp | +6pp | ||||
| Changes by quarters, q/q, % | +5pp | +7pp | -11pp | +6pp | ||||
